<DOC>
	<DOC>NCT01928862</DOC>
	<brief_summary>To study the efficacy and safety of Prepopik™ in children aged 9 to 16 years for overall colon cleansing in preparation of colonoscopy</brief_summary>
	<brief_title>Efficacy and Safety of Prepopik™ in Children for Overall Colon Cleansing in Preparation for Colonoscopy</brief_title>
	<detailed_description />
	<criteria>Male or female, aged 9 years to 16 years, inclusive, being scheduled to undergo elective colonoscopy Subjects must have had 3 or more spontaneous bowel movements per week for 1 month prior to the colonoscopy Female subjects of childbearing potential must undergo a pregnancy test at screening and again at randomization Acute surgical abdominal conditions (e.g., acute obstruction or perforation) Hospitalized for inflammatory bowel disease Any prior colorectal surgery, excluding appendectomy, hemorrhoid surgery, or prior endoscopic surgical procedures Colon disease (history of colonic cancer, toxic megacolon, toxic colitis, idiopathic pseudo obstruction, hypomotility syndrome, colon resection) Ascites Gastrointestinal disorder (active ulcer, outlet obstruction, retention, gastroparesis, ileus) Upper gastrointestinal surgery (gastric resection, gastric banding, gastric bypass) Significant cardiovascular disease as determined by the investigator If subject has a history of renal insufficiency, serum creatinine and potassium must be within normal limits Any clinically significant laboratory value at screening, including pre existing electrolyte abnormality, based on clinical history Hypersensitivity to active ingredients</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>